Hillary Clinton won't dampen pharma sector: Analyst

Despite a drop in biotech stocks this week after talk about price gouging, an analyst said Wednesday that the sector remains a good investment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.